The Statin Response Examined by Genetic Haplotype Markers (STRENGTH) study stated that the several variants in the SLCO1B1 gene, which encodes OATP1B1, affect the hepatic uptake of statins leading to myopathy [56-58]. This evidence concerns the gene SLCO1B1 and myopathy.